The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
The Surprising Way to Profit From the AI Boom: It’s Not Tech—It’s Real Estate
While most people chase AI stocks or compete for high‑pressure tech jobs, the real opportunity may be unfolding in AI boomtown real estate. As companies like OpenAI, Anthropic, Microsoft, and NVIDIA mint new waves of wealthy workers, demand for housing in key cities is exploding. From San Francisco to Austin, AI‑driven markets are seeing rising rents, limited inventory, and buyers preparing for massive IPO windfalls. For real estate professionals—or anyone entering the field—this surge represents one of the strongest long‑term opportunities in the industry.
